Promiscuous 2-Aminothiazoles (PrATs): A Frequent Hitting Scaffold

被引:72
|
作者
Devine, Shane M. [1 ]
Mulcair, Mark D. [1 ]
Debono, Cael O. [1 ]
Leung, Eleanor W. W. [1 ]
Nissink, J. Willem M. [2 ]
Lim, San Sui [1 ]
Chandrashekaran, Indu R. [1 ]
Vazirani, Mansha [1 ]
Mohanty, Biswaranjan [1 ]
Simpson, Jamie S. [1 ]
Baell, Jonathan B. [1 ]
Scammells, Peter J. [1 ]
Norton, Raymond S. [1 ]
Scanlon, Martin J. [1 ]
机构
[1] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia
[2] AstraZeneca, Oncol iMed, Cambridge CB4 0WG, England
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
VIRTUAL EXPLORATION; CHEMICAL UNIVERSE; DRUG; DISCOVERY; DESIGN; NMR; STRATEGIES; INHIBITORS; MOLECULES; LIBRARIES;
D O I
10.1021/jm501402x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We have identified a class of molecules, known as 2-aminothiazoles (2-ATs), as frequent-hitting fragments in biophysical binding assays. This was exemplified by 4-phenylthiazol-2-amine being identified as a hit in 14/14 screens against a diverse range of protein targets, suggesting that this scaffold is a poor starting point for fragment-based drug discovery. This prompted us to analyze this scaffold in the context of an academic fragment library used for fragment-based drug discovery (FBDD) and two larger compound libraries used for high-throughput screening (HTS). This analysis revealed that such "promiscuous 2-aminothiazoles" (PrATs) behaved as frequent hitters under both FBDD and HTS settings, although the problem was more pronounced in the fragment-based studies. As 2-ATs are present in known drugs, they cannot necessarily be deemed undesirable, but the combination of their promiscuity and difficulties associated with optimizing them into a lead compound makes them, in our opinion, poor scaffolds for fragment libraries.
引用
收藏
页码:1205 / 1214
页数:10
相关论文
共 49 条
  • [1] Recent developments of 2-aminothiazoles in medicinal chemistry
    Das, Debasis
    Sikdar, Papiya
    Bairagi, Moumita
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 109 : 89 - 98
  • [2] Real Multicomponent Reactions: Synthesis of Highly Substituted 2-Aminothiazoles
    Richter, Frank
    Seifert, Jennifer
    Korb, Marcus
    Lang, Heinrich
    Banert, Klaus
    EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2018, 2018 (34) : 4673 - 4682
  • [3] 2-Aminothiazoles as Therapeutic Leads for Prion Diseases
    Gallardo-Godoy, Alejandra
    Gever, Joel
    Fife, Kimberly L.
    Silber, B. Michael
    Prusiner, Stanley B.
    Renslo, Adam R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (04) : 1010 - 1021
  • [4] Synthesis of Starting Heterocycles: 2-Aminobenzothiazoles, 2-Aminothiazoles and 2-Aminobenzenethiols Potential Precursors for Macroheterocycles
    Sharma, Praveen Kumar
    MACROHETEROCYCLES, 2018, 11 (03): : 316 - 321
  • [5] Pharmacokinetics and Metabolism of 2-Aminothiazoles with Antiprion Activity in Mice
    Silber, B. Michael
    Rao, Satish
    Fife, Kimberly L.
    Gallardo-Godoy, Alejandra
    Renslo, Adam R.
    Dalvie, Deepak K.
    Giles, Kurt
    Freyman, Yevgeniy
    Elepano, Manuel
    Gever, Joel R.
    Li, Zhe
    Jacobson, Matthew P.
    Huang, Yong
    Benet, Leslie Z.
    Prusiner, Stanley B.
    PHARMACEUTICAL RESEARCH, 2013, 30 (04) : 932 - 950
  • [6] Efficient and facile strategy to substituted 2-aminothiazoles via ring opening of α-nitroepoxides
    Zhu, Yue
    Wang, Qilin
    Luo, Haofan
    Zhang, Guolin
    Yu, Yongping
    TETRAHEDRON, 2018, 74 (50) : 7143 - 7147
  • [7] QSAR STUDY OF ANTI-PRION ACTIVITY OF 2-AMINOTHIAZOLES
    Mandi, Prasit
    Nantasenamat, Chanin
    Srungboonmee, Kakanand
    Isarankura-Na-Ayudhya, Chartchalerm
    Prachayasittikul, Virapong
    EXCLI JOURNAL, 2012, 11 : 453 - 467
  • [8] Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents
    Kesicki, Edward A.
    Bailey, Mai A.
    Ovechkina, Yulia
    Early, Julie V.
    Alling, Torey
    Bowman, Julie
    Zuniga, Edison S.
    Dalai, Suryakanta
    Kumar, Naresh
    Masquelin, Thierry
    Hipskind, Philip A.
    Odingo, Joshua O.
    Parish, Tanya
    PLOS ONE, 2016, 11 (05):
  • [9] 2-Aminothiazoles with Improved Pharmacotherapeutic Properties for Treatment of Prion Disease
    Li, Zhe
    Silber, B. Michael
    Rao, Satish
    Gever, Joel R.
    Bryant, Clifford
    Gallardo-Godoy, Alejandra
    Dolghih, Elena
    Widjaja, Kartika
    Elepano, Manuel
    Jacobson, Matthew P.
    Prusiner, Stanley B.
    Renslo, Adam R.
    CHEMMEDCHEM, 2013, 8 (05) : 847 - 857
  • [10] Palladium-Catalyzed N-Arylation of 2-Aminothiazoles
    McGowan, Meredeth A.
    Henderson, Jaclyn L.
    Buchwald, Stephen L.
    ORGANIC LETTERS, 2012, 14 (06) : 1432 - 1435